Showing results (311-320 of 488) with videos related to
Sort By:
Pageof 49
Genome Research|December 25, 2015
TP53 regulates miRNA association with AGO2 to remodel the miRNA-mRNA interaction networkJonathan Krell, Justin Stebbing, Claudia Carissimi, et al.Physics in Medicine and Biology|March 12, 2019
Feasibility of multi-atlas cardiac segmentation from thoracic planning CT in a probabilistic frameworkRobert Finnegan, Jason Dowling, Eng-Siew Koh, et al.Journal of Medical Imaging and Radiation Oncology|April 11, 2025
An Assessment of Radiotherapy and Surgery Utilisation and Health Outcomes, in Aboriginal and Non-Aboriginal People With Cancer in NSW, Australia, 2009-2018Gabriel Gabriel, Kalinda Griffiths, Joseph Descallar, et al.Plos One|June 23, 2017
Correction: MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesotheliomaOmbretta Melaiu, Justin Stebbing, Ylenia Lombardo, et al.Molecular Cancer Therapeutics|August 5, 2017
The Tumor-Suppressor Protein OPCML Potentiates Anti-EGFR- and Anti-HER2-Targeted Therapy in HER2-Positive Ovarian and Breast CancerElisa Zanini, Louay S Louis, Jane Antony, et al.Oncotarget|March 22, 2018
Investigating the benefits of molecular profiling of advanced non-small cell lung cancer tumors to guide treatmentsCosti Alifrangis, Philip Carter, Biancastella Cereser, et al.Molecular Diagnosis & Therapy|April 12, 2012
The clinico-pathologic role of microRNAs miR-9 and miR-151-5p in breast cancer metastasisJonathan Krell, Adam E Frampton, Jimmy Jacob, et al.Future Oncology (London, England)|June 1, 2014
The prognostic role of circulating tumor cells in heavily pretreated individuals with a low life expectancyJustin Stebbing, Victoria Harding, Catherine E Urch, et al.Oncotarget|March 31, 2018
Correction: Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancyPhilip Carter, Costi Alifrangis, Biancastella Cereser, et al.Oncotarget|February 22, 2018
Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancyPhilip Carter, Costi Alifrangis, Biancastella Cereser, et al.Pageof 49